miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis. (Q42198057)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155445%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

title

miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155445%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155445%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Chuan-Feng Huang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155445%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Fang Zhao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155445%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Ya-Dong Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155445%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

De-Jia Li

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155445%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

publication date

26 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155445%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology

13 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155445%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155445%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155445%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

480-490

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155445%20AND%20SRC:MED&resulttype=core&format=json

Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve?

13 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Therapeutic targets in liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Evolving challenges in hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Circulating microRNAs in hepatitis B virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Induction of microRNA-214-5p in human and rodent liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Beyond secondary structure: primary-sequence determinants license pri-miRNA hairpins for processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Small non-coding RNAs in animal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

microRNA biogenesis pathway as a therapeutic target for human disease and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

MicroRNA epigenetics: a new avenue for wound healing research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

New role of microRNA: carcinogenesis and clinical application in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

microRNA involvement in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Differential microRNA expression profiles in peripheral arterial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

A regulatory role for microRNA 33* in controlling lipid metabolism gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Mir-33 regulates cell proliferation and cell cycle progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Hepatitis B virus infection status is an independent risk factor for multiple myeloma patients after autologous hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Targeting fibrosis in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Human primary cultured hepatic stellate cells can be cryopreserved.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Isolation and culture of primary hepatocytes from resected human liver tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

MiR-33 contributes to the regulation of cholesterol homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

MicroRNAs in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

The potential of microRNAs in liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Treatment of HCV infection by targeting microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Circulating microRNAs, potential biomarkers for drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Bone morphogenetic proteins: from developmental signals to tissue regeneration. Conference on bone morphogenetic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Regulation of TGF-beta signaling by Smad7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Smad7 in TGF-beta-mediated negative regulation of gut inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Disruption of the Smad7 gene enhances CCI4-dependent liver damage and fibrogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Micromanagement of the immune system by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

MicroRNA genetic variations: association with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0986-3

Vaccination against hepatitis B: the Chinese experience.

21 January 2018

1 reference

12 December 2020

Coexpression of Smad7 and UPA attenuates carbon tetrachloride-induced rat liver fibrosis

1 reference

12 December 2020

MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions

1 reference

12 December 2020

Isolation and culture of rat hepatic stellate cells

1 reference

12 December 2020

Liver fibrosis: from mechanisms to treatment

1 reference

12 December 2020

Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma

1 reference

12 December 2020

Isolation and culture of hepatic stellate cells

1 reference

12 December 2020

Classification of chronic hepatitis: diagnosis, grading and staging

1 reference

12 December 2020

Inhibitory Smad7: emerging roles in health and disease

1 reference

12 December 2020

Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis

1 reference

12 December 2020